Suppr超能文献

流式细胞术通过 Vβ 受体分析进行 T 细胞克隆性免疫表型评估:在诊断时检测 T 细胞克隆性和治疗后监测微小残留病。

Flow cytometric immunophenotypic assessment of T-cell clonality by Vβ repertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy.

机构信息

Flow Cytometry Unit, Laboratory of Pathology, National Cancer Institute/NIH, Bethesda, MD 20892, USA.

出版信息

Am J Clin Pathol. 2011 Jun;135(6):890-900. doi: 10.1309/AJCPV2D1DDSGJDBW.

Abstract

Flow cytometric T-cell receptor (TCR)-V(β) repertoire analysis (TCR-V(β)-R) is a sensitive method for detection of T-cell clonality; however, no uniform approach exists to define clonality in neoplastic T cells. TCR-V(β)-R was evaluated in patients with a diagnosis of T-cell neoplasia in initial diagnostic specimens from 41 patients and for minimal residual disease (MRD) monitoring in 61 sequential samples from 14 patients with mature T-cell neoplasia. Gating strategies and criteria for detection of T-cell clonality were determined. In all 41 initial specimens, T-cell clonality was demonstrated via TCR-V(β)-R. The frequency of V(β) usage was consistent with random neoplastic transformation of TCR-V(β) subsets. MRD was successfully detected in follow-up samples from all 14 patients evaluated, Furthermore, MRD after therapy was quantitated in 48 peripheral blood specimens. TCR-V(β)-R analysis is a sensitive method for detection of T-cell clonality and is useful for diagnosis and MRD detection in multiple specimen types.

摘要

流式细胞术 T 细胞受体(TCR)-V(β)谱系分析(TCR-V(β)-R)是检测 T 细胞克隆性的敏感方法;然而,目前尚不存在用于定义肿瘤性 T 细胞克隆性的统一方法。我们在 41 例 T 细胞肿瘤诊断初始标本中评估了 TCR-V(β)-R,并在 14 例成熟 T 细胞肿瘤患者的 61 个连续样本中进行了微小残留病(MRD)监测。确定了门控策略和检测 T 细胞克隆性的标准。在所有 41 例初始标本中,均通过 TCR-V(β)-R 显示 T 细胞克隆性。V(β)的使用频率与 TCR-V(β)亚群的随机肿瘤转化一致。对评估的 14 例患者的所有随访样本均成功检测到 MRD,此外,还对 48 份外周血样本进行了治疗后的 TCR-V(β)-R 分析。TCR-V(β)-R 分析是一种检测 T 细胞克隆性的敏感方法,可用于多种标本类型的诊断和 MRD 检测。

相似文献

引用本文的文献

1
An Update on Flow Cytometry Analysis of Hematological Malignancies: Focus on Standardization.
Cancers (Basel). 2025 Jun 19;17(12):2045. doi: 10.3390/cancers17122045.
3
Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application.
Mol Cancer. 2024 Feb 17;23(1):36. doi: 10.1186/s12943-024-01947-7.
4
The CXCL10-CXCR3 axis plays an important role in Kawasaki disease.
Clin Exp Immunol. 2024 Mar 12;216(1):104-111. doi: 10.1093/cei/uxad125.
6
CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphoma.
Front Immunol. 2023 Mar 2;14:1118681. doi: 10.3389/fimmu.2023.1118681. eCollection 2023.
7
Mature T-Cell leukemias: Challenges in Diagnosis.
Front Oncol. 2022 Mar 9;12:777066. doi: 10.3389/fonc.2022.777066. eCollection 2022.
10
Multiplexed single-cell morphometry for hematopathology diagnostics.
Nat Med. 2020 Mar;26(3):408-417. doi: 10.1038/s41591-020-0783-x. Epub 2020 Mar 11.

本文引用的文献

1
Variables affecting the quantitation of CD22 in neoplastic B cells.
Cytometry B Clin Cytom. 2011 Mar;80(2):83-90. doi: 10.1002/cyto.b.20567. Epub 2010 Sep 24.
2
Minimal residual disease detection by flow cytometry in adult T-cell leukemia/lymphoma.
Am J Clin Pathol. 2010 Apr;133(4):592-601. doi: 10.1309/AJCPS1K0OHLJYWWV.
4
Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells.
Cytometry B Clin Cytom. 2010 May;78(3):169-75. doi: 10.1002/cyto.b.20507.
7
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.
Leukemia. 2007 May;21(5):956-64. doi: 10.1038/sj.leu.2404584. Epub 2007 Mar 15.
8
Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating.
Am J Clin Pathol. 2005 Aug;124(2):199-204. doi: 10.1309/KEN4-MXM5-Y9A1-GEMP.
10
Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies.
Am J Clin Pathol. 2003 Nov;120(5):785-94. doi: 10.1309/835B-04QX-GNNF-NRJU.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验